This mechanism was validated in both diabetic mouse models and human renal tubular cell lines, suggesting that the mtDNA-cGAS-STING axis may be a key bridge connecting metabolic disorders and innate immune responses. The gene discussed is CGAS; the disease is metabolic disease.